About Samyang BioPharm
Samyang BioPharm is a company based in Seoul (South Korea) founded in 2011. Samyang BioPharm operates in a competitive market with competitors including Valeritas, scPharmaceuticals, Crossject, CeQur and Vaxxas, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Samyang Biopharm Co., Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Samyang BioPharm
Detailed funding history for Samyang BioPharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Samyang BioPharm
Investment portfolio details for Samyang BioPharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Samyang BioPharm
Detailed financials for Samyang BioPharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Samyang Biopharm Comparisons
Peer comparison for Samyang BioPharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Samyang BioPharm
Samyang BioPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Valeritas, scPharmaceuticals, Crossject, CeQur and Vaxxas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| Locked | Locked | Locked |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
|
| Locked | Locked | Locked |
Needle-free self-injectable drugs
|
|
| Locked | Locked | Locked |
Wearable insulin delivery patches are developed for mealtime dosing.
|
|
| Locked | Locked | Locked |
Developer of vaccines to treat cancer and infectious diseases
|
|
| Locked | Locked | Locked |
An endovascular device for treating abdominal aortic aneurysms is developed.
|
Detailed competitors of Samyang BioPharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Samyang Biopharm
Complete news archive for Samyang BioPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samyang BioPharm
Samyang BioPharm was founded in 2011.
Samyang BioPharm is headquartered in Seoul, South Korea.
Tae-Ung Eom is the current CEO of Samyang BioPharm.
Samyang BioPharm was founded in 2011 in Seoul, South Korea, and operates in the pharmaceutical and medical device sectors. Transdermal patches loaded with drugs such as menthol for joint pain relief, nicotine for smoking cessation, and nitroglycerin for angina prevention are researched and developed. Active pharmaceutical ingredients including paclitaxel, doxorubicin, and vancomycin are also produced. Wound closure products encompass surgical sutures, meshes, adhesion barriers, and hemostats.
Samyang BioPharm's top competitors include scPharmaceuticals, Mercator MedSystems and Crossject.